NKY 80

Pricing Availability   Qty
Description: Adenylyl cyclase inhibitor
Chemical Name: 2-Amino-7-(2-furanyl)-7,8-dihydro-5(6H)-quinazolinone
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (1)

Biological Activity for NKY 80

NKY 80 is an inhibitor of adenylyl cyclase (AC). Exhibits greater affinity for AC5 over AC3 and AC2 (IC50 values are 8.3 μM, 132 μM and 1.7 mM respectively).

Compound Libraries for NKY 80

NKY 80 is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.

Technical Data for NKY 80

M. Wt 229.23
Formula C12H11N3O2
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 299442-43-6
PubChem ID 2772368
InChI Key SOJUSNIBPPMLCC-UHFFFAOYSA-N
Smiles NC(N=C2)=NC1=C2C(CC(C3=CC=CO3)C1)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for NKY 80

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 22.92 100
ethanol 2.29 10 with gentle warming

Preparing Stock Solutions for NKY 80

The following data is based on the product molecular weight 229.23. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 4.36 mL 21.81 mL 43.62 mL
5 mM 0.87 mL 4.36 mL 8.72 mL
10 mM 0.44 mL 2.18 mL 4.36 mL
50 mM 0.09 mL 0.44 mL 0.87 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

References for NKY 80

References are publications that support the biological activity of the product.

Onda et al (2001) Type-specific regulation regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms. J.Biol.Chem. 276 47785 PMID: 11602596

Pierre et al (2009) Capturing adenylyl cyclases as potential drug targets. Nat.Rev.Drug Discov. 8 321 PMID: 19337273


If you know of a relevant reference for NKY 80, please let us know.

View Related Products by Product Action

View all Adenylyl Cyclase Inhibitors

Keywords: NKY 80, NKY 80 supplier, NKY80, adenylyl, cyclase, adenylate, inhibitors, inhibits, Adenylyl, Cyclase, 5071, Tocris Bioscience

Citations for NKY 80

Citations are publications that use Tocris products.

Currently there are no citations for NKY 80. Do you know of a great paper that uses NKY 80 from Tocris? Please let us know.

Reviews for NKY 80

There are currently no reviews for this product. Be the first to review NKY 80 and earn rewards!

Have you used NKY 80?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Schizophrenia Poster

Schizophrenia Poster

Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.